Drugmakers Seek Big Changes to 340B Mega-guidance

by Admin | November 20, 2015 12:44 pm

November 20, 2015—Brand-name drug and biotech companies are pleased with parts of the proposed 340B program guidance that would raise the prices hospitals pay for drugs. But in their comments to the Health Resources and Services Administration, the two main trade groups for branded drug manufacturers say the guidance doesn’t go far enough.  

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2015/11/drugmakers-seek-big-changes-to-340b-mega-guidance/

---